Henry D - Search Results

1

Erythropoiesis-stimulating agents: friends or foes?

Shander A, Ozawa S, Gross I, Henry D. Shander A, et al. Among authors: henry d. Transfusion. 2013 Sep;53(9):1867-72. doi: 10.1111/trf.12328. Transfusion. 2013. PMID: 24015936 No abstract available.

2

Management of anemia in patients with congestive heart failure.

Tim Goodnough L, Comin-Colet J, Leal-Noval S, Ozawa S, Takere J, Henry D, Javidroozi M, Hohmuth B, Bisbe E, Gross I, Shander A. Tim Goodnough L, et al. Among authors: henry d. Am J Hematol. 2017 Jan;92(1):88-93. doi: 10.1002/ajh.24595. Epub 2016 Dec 7. Am J Hematol. 2017. PMID: 27779769 Free article. Review.

3

On the safety of intravenous iron, evidence trumps conjecture.

Auerbach M, Adamson J, Bircher A, Breymann C, Fishbane S, Gafter-Gvili A, Gasche C, Gilreath J, Grazzini G, Henry D, Liumbruno G, Locatelli F, Macdougall I, Munoz M, Rampton D, Rodgers G, Shander A. Auerbach M, et al. Among authors: henry d. Haematologica. 2015 May;100(5):e214-5. doi: 10.3324/haematol.2014.121004. Haematologica. 2015. PMID: 25944640 Free PMC article. No abstract available.

4

Benefits and risks of using erythropoiesis-stimulating agents (ESAs) in lung cancer patients: study-level and patient-level meta-analyses.

Vansteenkiste J, Glaspy J, Henry D, Ludwig H, Pirker R, Tomita D, Collins H, Crawford J. Vansteenkiste J, et al. Among authors: henry d. Lung Cancer. 2012 Jun;76(3):478-85. doi: 10.1016/j.lungcan.2011.12.015. Epub 2012 Jan 25. Lung Cancer. 2012. PMID: 22277104 Free article.

5

Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?

Dahl NV, Henry DH, Coyne DW. Dahl NV, et al. Semin Dial. 2008 May-Jun;21(3):210-1. doi: 10.1111/j.1525-139X.2008.00435.x. Epub 2008 Apr 6. Semin Dial. 2008. PMID: 18397204

6

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron.

Henry DH, Dahl NV, Auerbach MA. Henry DH, et al. Am J Hematol. 2012 Mar;87(3):308-10. doi: 10.1002/ajh.22262. Epub 2012 Jan 20. Am J Hematol. 2012. PMID: 22262486 Free article.

7

Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.

Gawade PL, Berlin JA, Henry DH, Tomita D, Brooks BD, Franklin J, Bradbury BD, Critchlow CW. Gawade PL, et al. Among authors: henry dh. Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1357-1366. doi: 10.1002/pds.4293. Epub 2017 Aug 14. Pharmacoepidemiol Drug Saf. 2017. PMID: 28809079

8

Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future.

Henry DH, Volberding PA, Leitz G. Henry DH, et al. J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1221-7. doi: 10.1097/01.qai.0000135957.03791.ee. J Acquir Immune Defic Syndr. 2004. PMID: 15385728 Review.

9

Pharmacovigilance in practice: erythropoiesis-stimulating agents.

Hedenus M, Ludwig H, Henry DH, Gasal E. Hedenus M, et al. Cancer Med. 2014 Oct;3(5):1416-29. doi: 10.1002/cam4.275. Epub 2014 Jun 3. Cancer Med. 2014. PMID: 24890561 Free PMC article. Review.

10

Epoetin alfa for the treatment of cancer- and chemotherapy-related anaemia: product review and update.

Henry DH. Henry DH. Expert Opin Pharmacother. 2005 Feb;6(2):295-310. doi: 10.1517/14656566.6.2.295. Expert Opin Pharmacother. 2005. PMID: 15757425 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,409 results

Search Page

Filters